Expression of IL-17 and COX2 gene in peripheral blood leukocytes of vitiligo patients

Iranian Journal of Allergy, Asthma and Immunology

Volumn 10, Issue 2, 2011, Pages 81-89

  Esmaeili, Behnaz ^a   Rezaee, Seyed Abdol Rahim ^b   Layegh, Pouran ^c   Afshari, Jalil Tavakkol ^b   Dye, Phil ^d   Karimiani, Ehsan Ghayoor ^d   Kalalinia, Fatemeh ^e   Rafatpanah, Houshang ^f  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

COX2; IL 17; Neutrophils; Real time PCR; Vitiligo

Indexed keywords

COMPLEMENTARY DNA; CYCLOOXYGENASE 2; INTERLEUKIN 17;

ADULT; ARTICLE; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MALE; NEUTROPHIL; PATHOGENESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; VITILIGO;

ADOLESCENT; ADULT; CHILD; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-17; LEUKOCYTES; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; VITILIGO;

EID: 79959203528     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Rezaei N, Gavalas NG, Weetman AP, Kemp EH. Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol 2007; 21(7):865-76. (Pubitemid 47103715)
2. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16(3):208-14. (Pubitemid 36597056)
3. Birol A, Kisa U, Kurtipek GS, Kara F, Kocak M, Erkek E, et al. Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo. Int J Dermatol 2006; 45(8):992-3. (Pubitemid 44145043)
4. Yu HS, Chang KL, Yu CL, Li HF, Wu MT, Wu CS. Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo. J Invest Dermatol 1997; 108(4):527-9.
5. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL. gammadelta T cells: an important source of IL-17. Curr Opin Immunol 2008; 20(3):353-7.
6. Aarvak T, Chabaud M, Miossec P, Natvig JB. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 1999; 162(3):1246-51. (Pubitemid 29306992)
7. Shibata K, Yamada H, Hara H, Kishihara K, Yoshikai Y. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 2007; 178(7):4466-72. (Pubitemid 46492398)
8. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108(3):430-8. (Pubitemid 32881066)
9. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003; 170(4):2106-12. (Pubitemid 36197433)
10. Zhou Q, Desta T, Fenton M, Graves DT, Amar S. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect Immun 2005; 73(2):935-43. (Pubitemid 40165752)
11. Gaffen SL. Biology of recently discovered cytokines: interleukin-17 - a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res Ther 2004; 6(6):240-7. (Pubitemid 39490012)
12. Faour WH, Mancini A, He QW, Di Battista JA. T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3′-untranslated region of COX-2 mRNA. J Biol Chem 2003; 278(29):26897-907. (Pubitemid 36876841)
13. Voet D. Lipid Metabolism. In: Voet D, Voet JG. Biochemistry. 3nd. Wiley International Edition, 2004:963-5.
14. Glew R. Lipid Metabolism. Pathways of Metabolism of Special Lipids: Devlin T. Textbook of Biochemistry: With Clinical Correlations. Wiely Liss, 2006; 142:730-3.
15. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A. 1994; 91(25):12013-7. (Pubitemid 24368594)
16. Jandus C, Bioley G, Rivals JP, Dudler J, Speiser D, Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 2008; 58(8):2307-17.
17. Basak PY, Adiloglu AK, Ceyhan AM, Tas T, Akkaya VB. The role of helper and regulatory T cells in the pathogenesis of vitiligo. J Am Acad Dermatol 2009; 60(2):256-60.
18. Li M, Gao Y, Li C, Liu L, Li K, Gao L, et al. Association of COX2 functional polymorphisms and the risk of vitiligo in Chinese populations. J Dermatol Sci 2009; 53(3):176-81.
19. Mosher DB, Fitzpatric TB, Orton JP, Hori Y. Disorder of melanocytes. In: Fitzpatric T, Zeisen A, Wolf K, Freedberg FM, Austen KF. Dermatology in General Medicien. New York: McGraw-Hill Inc, 2008: 617-8.
20. Zhang X, Ding L, Sandford A. Selection of reference genes for gene expression studies in human neutrophils by real-time PCR. BMC Mol Biol 2005; 6(1):4.
21. Dheda K, Huggett J, Bustin S, Johnson M, Rook G, Zumla A. Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 2004; 37(1):112-9. (Pubitemid 38902668)
22. Ortonne. Vitiligo and other disorders of hypopigmentation. In: Bolognia JL, Jorizzo JL, Rapini RP, Horn TD, Mascaro JM, Mancini AJ, et al. Dermatology: Edinburg: Mosby, 2003.947-73.
23. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, et al. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment cell res 2002; 15(2):87-92. (Pubitemid 34536320)
24. Feldmann M, Brennan FM, Maini R. Cytokines in autoimmune disorders. Int Rev Immunol 1998; 17(1-4):217-28. (Pubitemid 29014551)
25. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995; 3(6):811-21. (Pubitemid 26091152)
26. Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, Wisniewska J, et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 2000; 165(10):5814-21
27. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999; 103(9):1345-52. (Pubitemid 29218305)
28. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 1998; 111(4):645-9. (Pubitemid 28452327)
29. Van den Boorn JG, Konijnenberg D, Dellemijn AM, van der Veen JP, Bos JD, et al. Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients. J Invest Dermatol 2009; 129(9):2220-32.
30. Pablos JL, Santiago B, Carreira PE, Galindo M, Gomez-Reino JJ. Cyclooxygenase-1 and-2 are expressed by human T cells. Clin Exp Immunol 1999; 115(1):86-90. (Pubitemid 29030367)
31. Niiro H ,Otsuka T, Izuhara K, Yamaoka K, Ohshima K, Tanabe T, et al. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 1997; 89(5):1621-8. (Pubitemid 27097455)
32. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC ,Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996; 97(11):2672-9. (Pubitemid 26187355)
33. Sun Y, Tang X, Half E, Kuo M, Sinicrope F. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer res 2002; 62(21):6323-8. (Pubitemid 35244488)
34. Colombe L, Vindrios A, Michelet JF, Bernard BA. Prostaglandin metabolism in human hair follicle. Exp Dermatol 2007; 16(9):762-9. (Pubitemid 47261868)
35. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003; 16(2):90-100. (Pubitemid 36596954)
36. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S ,Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183(6):2593-603. (Pubitemid 26193037)
37. Shalom-Barak T, Quach J, Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF- B. J Biol Chem 1998; 273(42):27467-73. (Pubitemid 28500465)
38. Lemos HP, Grespan R, Vieira SM, Cunha TM, Verri WA Jr, Fernandes KS, et al. Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc Natl Acad Sci U S A 2009; 106(14):5954-9.
39. van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000; 80(8):1299-309.
40. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, et al. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 2002; 15(2):87-92. (Pubitemid 34536320)
41. Ratsep R, Kingo K, Karelson M, Reimann E, Raud K, Silm H, et al. Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera. Br J Dermatol 2008; 159(6):1275-81.
42. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128(5):1207-11. (Pubitemid 351543220)